Azadeh Hajmirza, Ph.D.

Azadeh completed her M.Sc. and Ph.D. degrees at Grenoble Alpes University (France), during which she focused on the investigation of new epigenetic alterations presenting a therapeutic interest in aggressive subtypes of leukemia and lymphoma. She joined Dr. Sauvageau’s lab as a postdoctoral fellow in 2019 with a particular interest in exploring and targeting new cellular mechanisms responsible of treatment resistances in AML.